How does gut microbiome dysbiosis contribute to neuroinflammation and neurodegeneration through toll-like receptor TLR signaling and short-chain fatty acids SCFAs

How does gut microbiome dysbiosis contribute to neuroinflammation and neurodegeneration through toll-like receptor TLR signaling and short-chain fatty acids SCFAs

Resolution requires: (1) Germ-free or antibiotic-depleted mouse models reconstituted with human dysbiotic microbiomes demonstrate measurable increases in hippocampal/cortical neuroinflammatory markers (IL-1beta, TNF-alpha, IL-6 >=2-fold over SPF controls) with concurrent TLR4/TLR2 activation quantified by NF-kappaB reporter or ELISA in brain tissue; (2) SCFA profiling (butyrate, propionate, acetate by GC-MS) in matched stool and plasma showing >=40% reduction correlates with BBB permeability (TEER assay or Evans blue) and microglial activation (Iba1+/TMEM119- cells >=25% increase); (3) Mechanistic rescue: butyrate or propionate supplementation restores barrier integrity (TEER recovery >=80%) and reduces TLR-driven neuroinflammation in at least one validated neurodegeneration model (5xFAD, alpha-synuclein overexpression). Epidemiological association without mechanistic causation is insufficient.